Comparison of SCS and PMR in Patients With Refractory Angina Pectoris
An Open Single-Centre Parallel Randomised Trial of Spinal Cord Stimulation (SCS) and Percutaneous Myocardial Revascularisation (PMR) in Patients With Refractory Angina Pectoris
Sponsor: Medtronic
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Medtronic
Other Angina Pectoris trials with similar outcome
Listed as NCT00157742, this PHASE4 trial focuses on Angina Pectoris and remains terminated or withdrawn. Sponsored by Medtronic, it has been updated 5 times since 2000, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE4
First recorded
Sep 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic
For direct contact, visit the study record on ClinicalTrials.gov .